Literature DB >> 28087240

Lactobacillus-Deficient Cervicovaginal Bacterial Communities Are Associated with Increased HIV Acquisition in Young South African Women.

Christina Gosmann1, Melis N Anahtar1, Scott A Handley2, Mara Farcasanu3, Galeb Abu-Ali4, Brittany A Bowman3, Nikita Padavattan5, Chandni Desai2, Lindsay Droit2, Amber Moodley6, Mary Dong7, Yuezhou Chen8, Nasreen Ismail5, Thumbi Ndung'u9, Musie S Ghebremichael1, Duane R Wesemann8, Caroline Mitchell10, Krista L Dong7, Curtis Huttenhower4, Bruce D Walker11, Herbert W Virgin2, Douglas S Kwon12.   

Abstract

Elevated inflammation in the female genital tract is associated with increased HIV risk. Cervicovaginal bacteria modulate genital inflammation; however, their role in HIV susceptibility has not been elucidated. In a prospective cohort of young, healthy South African women, we found that individuals with diverse genital bacterial communities dominated by anaerobes other than Gardnerella were at over 4-fold higher risk of acquiring HIV and had increased numbers of activated mucosal CD4+ T cells compared to those with Lactobacillus crispatus-dominant communities. We identified specific bacterial taxa linked with reduced (L. crispatus) or elevated (Prevotella, Sneathia, and other anaerobes) inflammation and HIV infection and found that high-risk bacteria increased numbers of activated genital CD4+ T cells in a murine model. Our results suggest that highly prevalent genital bacteria increase HIV risk by inducing mucosal HIV target cells. These findings might be leveraged to reduce HIV acquisition in women living in sub-Saharan Africa.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  HIV acquisition; HIV susceptibility; female genital tract (FGT); mucosal immunology; sub-Saharan Africa; vaginal microbiome

Mesh:

Year:  2017        PMID: 28087240      PMCID: PMC5270628          DOI: 10.1016/j.immuni.2016.12.013

Source DB:  PubMed          Journal:  Immunity        ISSN: 1074-7613            Impact factor:   31.745


  33 in total

1.  Genital inflammation and the risk of HIV acquisition in women.

Authors:  Lindi Masson; Jo-Ann S Passmore; Lenine J Liebenberg; Lise Werner; Cheryl Baxter; Kelly B Arnold; Carolyn Williamson; Francesca Little; Leila E Mansoor; Vivek Naranbhai; Douglas A Lauffenburger; Katharina Ronacher; Gerhard Walzl; Nigel J Garrett; Brent L Williams; Mara Couto-Rodriguez; Mady Hornig; W Ian Lipkin; Anneke Grobler; Quarraisha Abdool Karim; Salim S Abdool Karim
Journal:  Clin Infect Dis       Date:  2015-04-21       Impact factor: 9.079

2.  HLA-DR+ CD38+ CD4+ T lymphocytes have elevated CCR5 expression and produce the majority of R5-tropic HIV-1 RNA in vivo.

Authors:  Amie L Meditz; Michelle K Haas; Joy M Folkvord; Kelsey Melander; Russ Young; Martin McCarter; Samantha Mawhinney; Thomas B Campbell; Yolanda Lie; Eoin Coakley; David N Levy; Elizabeth Connick
Journal:  J Virol       Date:  2011-08-03       Impact factor: 5.103

3.  Cervicovaginal bacteria are a major modulator of host inflammatory responses in the female genital tract.

Authors:  Melis N Anahtar; Elizabeth H Byrne; Kathleen E Doherty; Brittany A Bowman; Hidemi S Yamamoto; Magali Soumillon; Nikita Padavattan; Nasreen Ismail; Amber Moodley; Mary E Sabatini; Musie S Ghebremichael; Chad Nusbaum; Curtis Huttenhower; Herbert W Virgin; Thumbi Ndung'u; Krista L Dong; Bruce D Walker; Raina N Fichorova; Douglas S Kwon
Journal:  Immunity       Date:  2015-05-19       Impact factor: 31.745

4.  Altered Virome and Bacterial Microbiome in Human Immunodeficiency Virus-Associated Acquired Immunodeficiency Syndrome.

Authors:  Cynthia L Monaco; David B Gootenberg; Guoyan Zhao; Scott A Handley; Musie S Ghebremichael; Efrem S Lim; Alex Lankowski; Megan T Baldridge; Craig B Wilen; Meaghan Flagg; Jason M Norman; Brian C Keller; Jesús Mario Luévano; David Wang; Yap Boum; Jeffrey N Martin; Peter W Hunt; David R Bangsberg; Mark J Siedner; Douglas S Kwon; Herbert W Virgin
Journal:  Cell Host Microbe       Date:  2016-03-09       Impact factor: 21.023

5.  Low-level CD4+ T cell activation is associated with low susceptibility to HIV-1 infection.

Authors:  Fransje A Koning; Sigrid A Otto; Mette D Hazenberg; Linda Dekker; Maria Prins; Frank Miedema; Hanneke Schuitemaker
Journal:  J Immunol       Date:  2005-11-01       Impact factor: 5.422

6.  DADA2: High-resolution sample inference from Illumina amplicon data.

Authors:  Benjamin J Callahan; Paul J McMurdie; Michael J Rosen; Andrew W Han; Amy Jo A Johnson; Susan P Holmes
Journal:  Nat Methods       Date:  2016-05-23       Impact factor: 28.547

Review 7.  Intravaginal practices, bacterial vaginosis, and HIV infection in women: individual participant data meta-analysis.

Authors:  Nicola Low; Matthew F Chersich; Kurt Schmidlin; Matthias Egger; Suzanna C Francis; Janneke H H M van de Wijgert; Richard J Hayes; Jared M Baeten; Joelle Brown; Sinead Delany-Moretlwe; Rupert Kaul; Nuala McGrath; Charles Morrison; Landon Myer; Marleen Temmerman; Ariane van der Straten; Deborah Watson-Jones; Marcel Zwahlen; Adriane Martin Hilber
Journal:  PLoS Med       Date:  2011-02-15       Impact factor: 11.069

8.  Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2.

Authors:  Michael I Love; Wolfgang Huber; Simon Anders
Journal:  Genome Biol       Date:  2014       Impact factor: 13.583

Review 9.  Can one size fit all? Approach to bacterial vaginosis in sub-Saharan Africa.

Authors:  Zenda Woodman
Journal:  Ann Clin Microbiol Antimicrob       Date:  2016-03-11       Impact factor: 3.944

10.  Enhanced Trapping of HIV-1 by Human Cervicovaginal Mucus Is Associated with Lactobacillus crispatus-Dominant Microbiota.

Authors:  Kenetta L Nunn; Ying-Ying Wang; Dimple Harit; Michael S Humphrys; Bing Ma; Richard Cone; Jacques Ravel; Samuel K Lai
Journal:  MBio       Date:  2015-10-06       Impact factor: 7.867

View more
  230 in total

1.  Live attenuated varicella-zoster virus vaccine does not induce HIV target cell activation.

Authors:  Catia T Perciani; Bashir Farah; Rupert Kaul; Mario A Ostrowski; Salaheddin M Mahmud; Omu Anzala; Walter Jaoko; Kelly S MacDonald
Journal:  J Clin Invest       Date:  2019-01-22       Impact factor: 14.808

2.  A High-throughput Bead-based Affinity Assay Enables Analysis of Genital Protein Signatures in Women At Risk of HIV Infection.

Authors:  Anna Månberg; Frideborg Bradley; Ulrika Qundos; Brandon L Guthrie; Kenzie Birse; Laura Noël-Romas; Cecilia Lindskog; Rose Bosire; James Kiarie; Carey Farquhar; Adam D Burgener; Peter Nilsson; Kristina Broliden
Journal:  Mol Cell Proteomics       Date:  2018-11-30       Impact factor: 5.911

3.  Vaginal lactic acid elicits an anti-inflammatory response from human cervicovaginal epithelial cells and inhibits production of pro-inflammatory mediators associated with HIV acquisition.

Authors:  A C Hearps; D Tyssen; D Srbinovski; L Bayigga; D J D Diaz; M Aldunate; R A Cone; R Gugasyan; D J Anderson; G Tachedjian
Journal:  Mucosal Immunol       Date:  2017-04-12       Impact factor: 7.313

Review 4.  Topical Microbicides in HIV Prevention: State of the Promise.

Authors:  Jared M Baeten; Craig W Hendrix; Sharon L Hillier
Journal:  Annu Rev Med       Date:  2019-10-15       Impact factor: 13.739

5.  A FRESH approach: Combining basic science and social good.

Authors:  Thumbi Ndung'u; Krista L Dong; Douglas S Kwon; Bruce D Walker
Journal:  Sci Immunol       Date:  2018-09-14

6.  Correlates of HIV infection in adolescent girls and young women in Lesotho: results from a population-based survey.

Authors:  Andrea Low; Kyaw Thin; Stefania Davia; Joanne Mantell; Masebeo Koto; Stephen McCracken; Puleng Ramphalla; Limpho Maile; Nahima Ahmed; Hetal Patel; Bharat Parekh; Neway Fida; Amee Schwitters; Koen Frederix
Journal:  Lancet HIV       Date:  2019-08-14       Impact factor: 12.767

7.  Personal and Clinical Vaginal Lubricants: Impact on Local Vaginal Microenvironment and Implications for Epithelial Cell Host Response and Barrier Function.

Authors:  Ellen M Wilkinson; Paweł Łaniewski; Melissa M Herbst-Kralovetz; Rebecca M Brotman
Journal:  J Infect Dis       Date:  2019-11-06       Impact factor: 5.226

8.  Impact of Herpes Simplex Virus Type 2 and Human Immunodeficiency Virus Dual Infection on Female Genital Tract Mucosal Immunity and the Vaginal Microbiome.

Authors:  Marla J Keller; Ashley Huber; Lilia Espinoza; Myrna G Serrano; Hardik I Parikh; Gregory A Buck; Jeremy A Gold; Yiqun Wu; Tao Wang; Betsy C Herold
Journal:  J Infect Dis       Date:  2019-07-31       Impact factor: 5.226

Review 9.  Intestinal Lactobacillus in health and disease, a driver or just along for the ride?

Authors:  Dustin D Heeney; Mélanie G Gareau; Maria L Marco
Journal:  Curr Opin Biotechnol       Date:  2017-09-01       Impact factor: 9.740

10.  Evaluation of the association between the concentrations of key vaginal bacteria and the increased risk of HIV acquisition in African women from five cohorts: a nested case-control study.

Authors:  R Scott McClelland; Jairam R Lingappa; Sujatha Srinivasan; John Kinuthia; Grace C John-Stewart; Walter Jaoko; Barbra A Richardson; Krista Yuhas; Tina L Fiedler; Kishorchandra N Mandaliya; Matthew M Munch; Nelly R Mugo; Craig R Cohen; Jared M Baeten; Connie Celum; Julie Overbaugh; David N Fredricks
Journal:  Lancet Infect Dis       Date:  2018-01-26       Impact factor: 25.071

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.